Mike de Leeuw was invited to write an expert column in a special feature of ‘Het Financieel Dagblad’ covering a.o. oncology development in the Netherlands. You can read the column here.
OncoLize raising Series A round of €8.5 Million to treat aggressive tumors
OncoLize is preparing first clinical trials to treat pancreatic tumors. Based on solid Proof-of-Concept data and its proprietary OCL platform the company will raise €8.5 Million in two steps. This will start trials in the Read more…